Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial.
Valéa I, Adjei S, Usuf E, Traore O, Ansong D, Tinto H, Owusu Boateng H, Some AM, Buabeng P, Vekemans J, Kotey A, Vandoolaeghe P, Cullinane M, Traskine M, Ouedraogo F, Sambian D, Lievens M, Tahita MC, Jongert E, Lompo P, Idriss A, Borys D, Ouedraogo S, Prempeh F, Schuerman L, Sorgho H, Agbenyega T.
Valéa I, et al.
Hum Vaccin Immunother. 2020 Jun 2;16(6):1464-1470. doi: 10.1080/21645515.2019.1695457. Epub 2020 Jan 17.
Hum Vaccin Immunother. 2020.
PMID: 31951771
Free PMC article.
Clinical Trial.
RTS,S/AS01(E) malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. To evaluate the impact of RTS,S/AS01(E) when implemented in the Expanded Program of Immunization, infants 8-12 weeks old were randomized to r …
RTS,S/AS01(E) malaria vaccine contains the hepatitis B virus surface antigen and may thus serve as a potential hepatitis B vaccine. T …